Bleeding and Blood Transfusion in MVR

NCT05594420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-10-26

No results posted yet for this study

Summary

To identify the best approach for mitral valve replacement to decrease risk of bleeding and restrict blood transfusion and its complication.

Conditions

  • Mitral Valve Disease

Interventions

PROCEDURE

Mitral valve replacement

Mitral valve replacement through median sternotomy and minimally invasive approach

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2024-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05594420 on ClinicalTrials.gov